Wellgistics Health, Inc. (WGRX): Nasdaq/NYSE listing notice — Wellgistics Health receives Nasdaq bid-price deficiency notice; 180-day cure period through June 8, 2026

Wellgistics Health, Inc.

Stock closed below $1.00 for 30 consecutive business days (Oct 27–Dec 9, 2025); violates Nasdaq Listing Rule 5550(a)(2).
Nasdaq grants 180 calendar days (to June 8, 2026) to regain compliance; eligible for additional 180-day period if other listing standards met.
Company evaluating options, including a potential reverse stock split; no immediate effect on listing under symbol WGRX.
Failure to cure could result in delisting; appeal to Nasdaq hearings panel would be available.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Wellgistics Health, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

December 9, 2025, the common stock of the Company had not maintained a minimum closing bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company was provided an initial period of 180 calendar days, or until June 8, 2026 (the “Compliance Period”), to regain compliance with the Bid Price Rule. If the Company does not regain compliance with the Bid Price Rule by June 8, 2026, the Company may be eligible for an additional 180-day period to reg

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Wellgistics Health, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-027830

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.